224 related articles for article (PubMed ID: 26394880)
41. Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review.
Kmiotek E; Lakda S; Borakati A; Ogunbiyi O; Mandair D; Caplin M; Toumpanakis C; Mirnezami R
Curr Oncol; 2023 Oct; 30(10):9192-9204. PubMed ID: 37887564
[TBL] [Abstract][Full Text] [Related]
42. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?
Maxwell JE; Sherman SK; O'Dorisio TM; Bellizzi AM; Howe JR
Surgery; 2016 Jan; 159(1):320-33. PubMed ID: 26454679
[TBL] [Abstract][Full Text] [Related]
43. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
[TBL] [Abstract][Full Text] [Related]
44. Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study.
Le Roux C; Lombard-Bohas C; Delmas C; Dominguez-Tinajero S; Ruszniewski P; Samalin E; Raoul JL; Renard P; Baudin E; Robaskiewicz M; Mitry E; Cadiot G;
Dig Liver Dis; 2011 Oct; 43(10):828-33. PubMed ID: 21641888
[TBL] [Abstract][Full Text] [Related]
45. Preoperative
Norlén O; Montan H; Hellman P; Stålberg P; Sundin A
World J Surg; 2018 Feb; 42(2):498-505. PubMed ID: 29159606
[TBL] [Abstract][Full Text] [Related]
46. [Surgical aspects of neuroendocrine tumors of the small intestine].
Weber F; Dralle H
Chirurg; 2018 Jun; 89(6):428-433. PubMed ID: 29464306
[TBL] [Abstract][Full Text] [Related]
47. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
[TBL] [Abstract][Full Text] [Related]
48. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP
J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
Jiang S; Zhao L; Xie C; Su H; Yan Y
Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
[No Abstract] [Full Text] [Related]
50. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
Roberts J; Gonzalez RS; Revetta F; Shi C
Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
[TBL] [Abstract][Full Text] [Related]
51. Laparoscopic assisted central mesenteric lymph node dissection with bowel sparing resection of small bowel neuroendocrine tumours using fluorescence angiography - a video vignette.
Kaçmaz E; Slooter MD; Nieveen van Dijkum EJM; Tanis PJ; Engelsman AF
Colorectal Dis; 2019 Jun; 21(6):724-725. PubMed ID: 30895686
[No Abstract] [Full Text] [Related]
52. Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients < or = 40 years: an overview based on our case material and the literature.
Agaimy A; Wünsch PH
Langenbecks Arch Surg; 2009 Mar; 394(2):375-81. PubMed ID: 19104826
[TBL] [Abstract][Full Text] [Related]
53. The evolving role of imaging for small bowel neuroendocrine neoplasms: estimated impact of imaging and disease-free survival in a retrospective observational study.
Kim S; Marcus R; Wells ML; Sheedy SP; Hansel SL; Bruining DH; Barlow JM; Carter RE; Lee YS; Johnson MP; Fidler JL; Goenka AH; McCollough CH; Fletcher JG
Abdom Radiol (NY); 2020 Mar; 45(3):623-631. PubMed ID: 31980866
[TBL] [Abstract][Full Text] [Related]
54. Neuroendocrine tumours of the small intestine.
Strosberg J
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):755-73. PubMed ID: 23582917
[TBL] [Abstract][Full Text] [Related]
55. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
56. Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy.
Bellutti M; Fry LC; Schmitt J; Seemann M; Klose S; Malfertheiner P; Mönkemüller K
Dig Dis Sci; 2009 May; 54(5):1050-8. PubMed ID: 18770038
[TBL] [Abstract][Full Text] [Related]
57. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
58. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
Shi C; Gonzalez RS; Zhao Z; Koyama T; Cornish TC; Hande KR; Walker R; Sandler M; Berlin J; Liu EH
Am J Clin Pathol; 2015 Mar; 143(3):398-404. PubMed ID: 25696798
[TBL] [Abstract][Full Text] [Related]
59. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
60. The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis.
Ejaz A; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss M; Marques HP; Aldrighetti L; Pawlik TM
J Surg Oncol; 2017 Dec; 116(7):841-847. PubMed ID: 28650564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
